[1] GuoX,ChenL,LangR, 2006.Invasive micropapillary carcinoma of the breast;association of pathologic features with lymph node metastasis[J],Am J ClinPathol 126 740 -746
[2] 2004.Diagnosis of breast invasive papillary carcinoma,Chinese Journal of Pathology 33 305 -307
[3] FuL,Song ShanYS,FuX Y, 2004.eTh relationship between morphological changes and biological behavior of breast invasive papillary carcinoma,Chinese Journal of Pathology 33 21 -25
[4] TavassaoeliFA,DavileeP, 2003.Pathology and Genetics of Tumours of the Breast and Female Genital Organs,Lyon: lARC Press WHO 28 -29
[5] Reis-FilhoJS,EllisIO, 2012.WHO classification of tumours of the breast[Z], 65 -66
[6] LiuF,LangR,WeiJ, 2009.Increased expression of SDF-1/CXCR4 is associated with lymph node metastasis of invasive micro papillary carcinoma of the breast,Histopathology 54 741 -750
[7] HammondME,HayesDF,DowsettM, 2010.American Society of Clinical Oncology / College Of American Pathologists guideline recommendations for immimo histochemical testing of estrogen and progesterone receptors in breast cancer [J],J ClinOncol 28 2784 -2795
[8] WolfAC,HammondME,SchwartzJN, 2007.American Society of Clinical Oncology/ College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer[J],J ClinOncol 25 118 -145